Complement C3, eosinophil cationic protein and symptom evaluation in interstitial cystitis.
Interstitial cystitis is a painful, irritative voiding dysfunction of unknown etiology. In this study 19 women undergoing treatment for interstitial cystitis and 6 healthy women of similar age provided 2 urine and serum specimens with at least a 3-month interval between collections. Complement C3 and eosinophil cationic protein were determined by immunoassay methods, and symptom severity was quantitated with a visual analog scale questionnaire. Concentrations of complement C3 and eosinophil cationic protein from either serum or urine were not significantly different between interstitial cystitis patients and controls at either determination, although substantial differences were noted even between individual initial and followup determinations. Normalization of urine osmolality did not alter these results. Symptom severity scores were significantly greater in interstitial cystitis patients compared to controls but failed to correlate with the concentrations of complement C3 or eosinophil cationic protein. Therefore, the hypothesis that complement C3 and eosinophil cationic protein may be etiological factors of interstitial cystitis is not supported.
Steinert
B W
BW
Department of Urology, William Beaumont Hospital, Royal Oak, Michigan.
Diokno
A C
AC
Robinson
J E
JE
Mitchell
B A
BA
D000328:Adult; D001798:Blood Proteins / Q000032:analysis*; D015932:Complement C3c / Q000032:analysis*; D003556:Cystitis / Q000097:blood / Q000175:diagnosis* / Q000652:urine; D047091:Eosinophil Granule Proteins; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010147:Pain Measurement; D012260:Ribonucleases; D012720:Severity of Illness Index
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D015932:Complement C3c; D012260:Ribonucleases